Document is current

Any future updates will be listed below

SGLT2 inhibitors and their role in reducing mortality among cancer patients with type 2 diabetes undergoing immune checkpoint inhibitor therapy

Crossref DOI link: https://doi.org/10.1007/s12672-025-04046-1

Published Online: 2025-11-17

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark